Home/ Supplements/ St Johns Wort/ Neuro Clarity

Neuro Clarity

product on market Capsule Nutrition Essentials Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile includes Bacopa monnieri and Phosphatidylserine, which have moderate evidence for supporting cognitive function. N-Acetyl L-Carnitine and L-Glutamine are included for metabolic and neurological support, though evidence for these specific applications is more limited. St. John's Wort is widely studied for mood regulation.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Neuro Clarity
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 300.0mg (240 products) 20 studies — no high-quality reviews
150 mg
Market median: 420.0mg (227 products)
Market median: 100.0mg (108 products)
Bacopa monnieri leaf extract
75 mg
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
DMAE
50 mg
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
50 mg
Market median: 400.0mg (73 products) 15 studies (A:0, B:5)
Neem
35 mg

Other Ingredients

Rice Flour
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, adults take two (2) capsules per day. Do not exceed 2 capsules per day.

Warnings & Precautions

Do not exceed recommended dose. St. John's wort may contribute to photosensitivity resulting in skin irritation and redness in persons exposed to strong sunlight or tanning booths. Avoid in patients at risk of bleeding, taking anticoagulants, or with clotting disorders, based on case reports of bleeding. Discontinue use 2-3 weeks prior to some surgical and dental procedures due to increased risk of bleeding. Use cautiously in patients with history of seizure, based on reports of seizure due to ginkgo seed ingestion.

Not intended for children under 18 years of age.

Avoid use in couples who are trying to conceive, based on theoretical reduction of fertility.

Pregnant or nursing mothers, children under 18, individuals making mao inhibiting drugs, or with a known medical condition should consult a physician before using this or any dietary supplement.

Pregnant or nursing mothers, children under 18, individuals making mao inhibiting drugs, or with a known medical condition should consult a physician before using this or any dietary supplement.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, fish, and crustacean shellfish.

Keep out of reach of children.

Do not use if seal is damaged or missing.

Formulation Notes

Supports focus, memory, and brain clarity.

With ginkgo biloba. Strong, potent formula.

Results guaranteed.

Additional Information

Store in room temperature.

GMP Good Manufacturing Practice Followed

Metadata

Product Details

UPC / SKUX000SA99ZF
DSLD Entry Date2022-08-23
Product TypeOther Combinations
FormCapsule
DSLD ID271766
Data Updated2026-04-11
Research

Research Evidence

43
Research Sources
48
Avg Quality
16
Meta Analysis
14
Systematic Review
7
Rct
4
Regulatory Source
1
Clinical Trial
1
Openfda Safety
B St John's wort for major depression
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
B Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
Meta Analysis Journal of affective disorders 2017 PubMed DOI
B A systematic review of St. John's wort for major depressive disorder
Meta Analysis Systematic reviews 2016 PubMed DOI
B St John's wort for depression
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis
Meta Analysis Neuropsychopharmacology reports 2025 PubMed DOI
B St John's wort for depression
Meta Analysis The Cochrane database of systematic reviews 2005 PubMed
C St John's wort for depression: meta-analysis of randomised controlled trials
Meta Analysis The British journal of psychiatry : the journal of mental science 2005 PubMed
C The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial
Rct Complementary therapies in medicine 2019 PubMed DOI
C Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks
Rct BMJ (Clinical research ed.) 1999 PubMed
C Hypericum perforatum as a cognitive enhancer in rodents: A meta-analysis
Meta Analysis Scientific reports 2016 PubMed DOI
View all evidence for St Johns Wort →
Compare

Similar Products

View all St Johns Wort products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.